ID   REV1_HUMAN              Reviewed;        1251 AA.
AC   Q9UBZ9; O95941; Q53SI7; Q9C0J4; Q9NUP2;
DT   15-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-JUL-2015, entry version 127.
DE   RecName: Full=DNA repair protein REV1;
DE            EC=2.7.7.-;
DE   AltName: Full=Alpha integrin-binding protein 80;
DE            Short=AIBP80;
DE   AltName: Full=Rev1-like terminal deoxycytidyl transferase;
GN   Name=REV1; Synonyms=REV1L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Bone marrow, Leukocyte, and T-cell;
RX   PubMed=10536157; DOI=10.1093/nar/27.22.4468;
RA   Lin W., Xin H., Zhang X., Wu X., Yuan F., Wang Z.;
RT   "The human REV1 gene codes for a DNA template-dependent dCMP
RT   transferase.";
RL   Nucleic Acids Res. 27:4468-4475(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND ROLE IN UV-INDUCED
RP   MUTAGENESIS.
RC   TISSUE=Brain;
RX   PubMed=10760286; DOI=10.1073/pnas.97.8.4186;
RA   Gibbs P.E.M., Wang X.-D., Li Z., McManus T.P., McGregor W.G.,
RA   Lawrence C.W., Maher V.M.;
RT   "The function of the human homolog of Saccharomyces cerevisiae REV1 is
RT   required for mutagenesis induced by UV light.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:4186-4191(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, MUTAGENESIS
RP   OF ASP-570 AND GLU-571, AND TISSUE SPECIFICITY.
RC   TISSUE=Mammary cancer, and Testis;
RX   PubMed=11278384; DOI=10.1074/jbc.M008082200;
RA   Masuda Y., Takahashi M., Tsunekuni N., Minami T., Sumii M.,
RA   Miyagawa K., Kamiya K.;
RT   "Deoxycytidyl transferase activity of the human REV1 protein is
RT   closely associated with the conserved polymerase domain.";
RL   J. Biol. Chem. 276:15051-15058(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND INTERACTION WITH REV3L AND MAD2L2.
RC   TISSUE=Testis;
RX   PubMed=11485998; DOI=10.1074/jbc.M102051200;
RA   Murakumo Y., Ogura Y., Ishii H., Numata S., Ichihara M., Croce C.M.,
RA   Fishel R., Takahashi M.;
RT   "Interactions in the error-prone postreplication repair proteins
RT   hREV1, hREV3, and hREV7.";
RL   J. Biol. Chem. 276:35644-35651(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 479-1251 (ISOFORM 2), AND INTERACTION
RP   WITH ITGA3.
RC   TISSUE=Placenta;
RX   PubMed=10094488; DOI=10.1016/S0014-5793(99)00151-9;
RA   Wixler V., Laplantine E., Geerts D., Sonnenberg A., Petersohn D.,
RA   Eckes B., Paulsson M., Aumailley M.;
RT   "Identification of novel interaction partners for the conserved
RT   membrane proximal region of alpha-integrin cytoplasmic domains.";
RL   FEBS Lett. 445:351-355(1999).
RN   [8]
RP   INTERACTION WITH MAD2L2.
RX   PubMed=12529368; DOI=10.1074/jbc.M211765200;
RA   Masuda Y., Ohmae M., Masuda K., Kamiya K.;
RT   "Structure and enzymatic properties of a stable complex of the human
RT   REV1 and REV7 proteins.";
RL   J. Biol. Chem. 278:12356-12360(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   INTERACTION WITH DNA POLYMERASE ZETA.
RX   PubMed=20164194; DOI=10.1074/jbc.M109.092403;
RA   Hara K., Hashimoto H., Murakumo Y., Kobayashi S., Kogame T., Unzai S.,
RA   Akashi S., Takeda S., Shimizu T., Sato M.;
RT   "Crystal structure of human REV7 in complex with a human REV3 fragment
RT   and structural implication of the interaction between DNA polymerase
RT   zeta and REV1.";
RL   J. Biol. Chem. 285:12299-12307(2010).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH C1ORF86.
RX   PubMed=22266823; DOI=10.1038/nsmb.2222;
RA   Kim H., Yang K., Dejsuphong D., D'Andrea A.D.;
RT   "Regulation of Rev1 by the Fanconi anemia core complex.";
RL   Nat. Struct. Mol. Biol. 19:164-170(2012).
RN   [12]
RP   STRUCTURE BY NMR OF 43-133.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the BRCT domain from human DNA repair protein
RT   REV1.";
RL   Submitted (AUG-2007) to the PDB data bank.
CC   -!- FUNCTION: Deoxycytidyl transferase involved in DNA repair.
CC       Transfers a dCMP residue from dCTP to the 3'-end of a DNA primer
CC       in a template-dependent reaction. May assist in the first step in
CC       the bypass of abasic lesions by the insertion of a nucleotide
CC       opposite the lesion. Required for normal induction of mutations by
CC       physical and chemical agents. {ECO:0000269|PubMed:10536157,
CC       ECO:0000269|PubMed:10760286, ECO:0000269|PubMed:11278384,
CC       ECO:0000269|PubMed:11485998, ECO:0000269|PubMed:22266823}.
CC   -!- SUBUNIT: Monomer. Interacts with the DNA polymerase zeta which is
CC       composed of REV3L and MAD2L2; the interaction with MAD2L2 is
CC       direct and requires that REV3L is in its closed conformation.
CC       Interacts with POLH, POLI and POLK. May bind ITGA3. Interacts with
CC       FAAP20/C1orf86. {ECO:0000269|PubMed:10094488,
CC       ECO:0000269|PubMed:11485998, ECO:0000269|PubMed:12529368,
CC       ECO:0000269|PubMed:20164194, ECO:0000269|PubMed:22266823}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=REV1;
CC         IsoId=Q9UBZ9-1; Sequence=Displayed;
CC       Name=2; Synonyms=REV1S;
CC         IsoId=Q9UBZ9-2; Sequence=VSP_012812;
CC       Name=3;
CC         IsoId=Q9UBZ9-3; Sequence=VSP_012809, VSP_012810, VSP_012811;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10536157,
CC       ECO:0000269|PubMed:11278384, ECO:0000269|PubMed:11485998}.
CC   -!- DOMAIN: The C-terminal domain is necessary for protein
CC       interactions.
CC   -!- SIMILARITY: Belongs to the DNA polymerase type-Y family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 BRCT domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00033}.
CC   -!- SIMILARITY: Contains 1 umuC domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00216}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK43708.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF151538; AAF06731.1; -; mRNA.
DR   EMBL; AF206019; AAF18986.1; -; mRNA.
DR   EMBL; AB047646; BAB21441.1; -; mRNA.
DR   EMBL; AF357886; AAK43708.1; ALT_INIT; mRNA.
DR   EMBL; AK002087; BAA92079.1; -; mRNA.
DR   EMBL; AC018690; AAY24314.1; -; Genomic_DNA.
DR   EMBL; AJ131720; CAB38231.1; -; mRNA.
DR   CCDS; CCDS2045.1; -. [Q9UBZ9-1]
DR   CCDS; CCDS42722.1; -. [Q9UBZ9-2]
DR   RefSeq; NP_001032961.1; NM_001037872.1. [Q9UBZ9-2]
DR   RefSeq; NP_057400.1; NM_016316.2. [Q9UBZ9-1]
DR   UniGene; Hs.443077; -.
DR   PDB; 2EBW; NMR; -; A=44-133.
DR   PDB; 2LSI; NMR; -; A=1156-1251.
DR   PDB; 2LSK; NMR; -; A=1158-1251.
DR   PDB; 2LSY; NMR; -; A=1158-1251.
DR   PDB; 3GQC; X-ray; 2.50 A; A/B/C/D=330-833.
DR   PDB; 3VU7; X-ray; 2.80 A; H=1140-1251.
DR   PDB; 4BA9; X-ray; 2.73 A; A/B/C/D/E/F=1158-1242.
DR   PDB; 4EXT; X-ray; 1.90 A; A=1156-1251.
DR   PDB; 4GK0; X-ray; 2.70 A; E/F=1117-1251.
DR   PDB; 4GK5; X-ray; 3.21 A; E/F=1117-1251.
DR   PDBsum; 2EBW; -.
DR   PDBsum; 2LSI; -.
DR   PDBsum; 2LSK; -.
DR   PDBsum; 2LSY; -.
DR   PDBsum; 3GQC; -.
DR   PDBsum; 3VU7; -.
DR   PDBsum; 4BA9; -.
DR   PDBsum; 4EXT; -.
DR   PDBsum; 4GK0; -.
DR   PDBsum; 4GK5; -.
DR   ProteinModelPortal; Q9UBZ9; -.
DR   SMR; Q9UBZ9; 48-133, 344-828, 1156-1251.
DR   BioGrid; 119551; 19.
DR   IntAct; Q9UBZ9; 3.
DR   MINT; MINT-140323; -.
DR   STRING; 9606.ENSP00000258428; -.
DR   PhosphoSite; Q9UBZ9; -.
DR   BioMuta; REV1; -.
DR   DMDM; 59798439; -.
DR   MaxQB; Q9UBZ9; -.
DR   PaxDb; Q9UBZ9; -.
DR   PRIDE; Q9UBZ9; -.
DR   Ensembl; ENST00000258428; ENSP00000258428; ENSG00000135945.
DR   Ensembl; ENST00000393445; ENSP00000377091; ENSG00000135945. [Q9UBZ9-2]
DR   GeneID; 51455; -.
DR   KEGG; hsa:51455; -.
DR   UCSC; uc002tac.3; human. [Q9UBZ9-2]
DR   UCSC; uc002tad.3; human. [Q9UBZ9-1]
DR   UCSC; uc002tae.1; human. [Q9UBZ9-3]
DR   CTD; 51455; -.
DR   GeneCards; GC02M100016; -.
DR   HGNC; HGNC:14060; REV1.
DR   HPA; HPA044534; -.
DR   HPA; HPA051036; -.
DR   MIM; 606134; gene.
DR   neXtProt; NX_Q9UBZ9; -.
DR   PharmGKB; PA162401120; -.
DR   eggNOG; COG0389; -.
DR   GeneTree; ENSGT00530000062942; -.
DR   HOGENOM; HOG000154094; -.
DR   HOVERGEN; HBG054140; -.
DR   InParanoid; Q9UBZ9; -.
DR   KO; K03515; -.
DR   OMA; YRFCRGL; -.
DR   OrthoDB; EOG761BTT; -.
DR   PhylomeDB; Q9UBZ9; -.
DR   TreeFam; TF314488; -.
DR   Reactome; REACT_355158; Translesion synthesis by POLK.
DR   Reactome; REACT_355250; Termination of translesion DNA synthesis.
DR   Reactome; REACT_355324; Translesion synthesis by POLI.
DR   Reactome; REACT_8; Translesion synthesis by REV1.
DR   SignaLink; Q9UBZ9; -.
DR   ChiTaRS; REV1; human.
DR   EvolutionaryTrace; Q9UBZ9; -.
DR   GeneWiki; REV1; -.
DR   GenomeRNAi; 51455; -.
DR   NextBio; 55069; -.
DR   PRO; PR:Q9UBZ9; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; Q9UBZ9; -.
DR   CleanEx; HS_REV1; -.
DR   ExpressionAtlas; Q9UBZ9; baseline and differential.
DR   Genevisible; Q9UBZ9; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0003684; F:damaged DNA binding; TAS:ProtInc.
DR   GO; GO:0017125; F:deoxycytidyl transferase activity; IEA:Ensembl.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IEA:InterPro.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0006281; P:DNA repair; TAS:Reactome.
DR   GO; GO:0006260; P:DNA replication; TAS:ProtInc.
DR   GO; GO:0042276; P:error-prone translesion synthesis; TAS:UniProtKB.
DR   GO; GO:0009411; P:response to UV; IDA:UniProtKB.
DR   GO; GO:0019985; P:translesion synthesis; TAS:Reactome.
DR   Gene3D; 3.30.1490.100; -; 1.
DR   Gene3D; 3.40.50.10190; -; 1.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR017961; DNA_pol_Y-fam_little_finger.
DR   InterPro; IPR001126; DNA_repair_prot_UmuC-like.
DR   InterPro; IPR017963; DNA_repair_prot_UmuC-like_N.
DR   InterPro; IPR012112; REV1.
DR   PANTHER; PTHR11076:SF13; PTHR11076:SF13; 1.
DR   Pfam; PF00533; BRCT; 1.
DR   Pfam; PF00817; IMS; 1.
DR   Pfam; PF11799; IMS_C; 1.
DR   PIRSF; PIRSF036573; REV1; 1.
DR   SMART; SM00292; BRCT; 1.
DR   SUPFAM; SSF100879; SSF100879; 1.
DR   SUPFAM; SSF52113; SSF52113; 1.
DR   PROSITE; PS50172; BRCT; 1.
DR   PROSITE; PS50173; UMUC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; DNA damage;
KW   DNA repair; DNA synthesis; DNA-binding; Magnesium; Metal-binding;
KW   Nucleotidyltransferase; Nucleus; Polymorphism; Reference proteome;
KW   Transferase.
FT   CHAIN         1   1251       DNA repair protein REV1.
FT                                /FTId=PRO_0000173992.
FT   DOMAIN       44    131       BRCT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00033}.
FT   DOMAIN      419    653       UmuC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00216}.
FT   NP_BIND     423    427       dCTP binding. {ECO:0000250}.
FT   NP_BIND     510    516       dCTP binding. {ECO:0000250}.
FT   REGION      352    362       Interaction with target DNA.
FT                                {ECO:0000250}.
FT   REGION      653    656       Interaction with target DNA.
FT                                {ECO:0000250}.
FT   REGION      709    717       Interaction with target DNA.
FT                                {ECO:0000250}.
FT   REGION     1150   1249       Protein interaction domain; mediates
FT                                interaction with DNA polymerase zeta.
FT   MOTIF      1071   1078       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   METAL       423    423       Magnesium 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00216}.
FT   METAL       423    423       Magnesium 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00216}.
FT   METAL       570    570       Magnesium 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00216}.
FT   METAL       571    571       Magnesium 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00216}.
FT   BINDING     357    357       dCTP. {ECO:0000250}.
FT   BINDING     522    522       dCTP. {ECO:0000250}.
FT   BINDING     570    570       dCTP. {ECO:0000250}.
FT   SITE        770    770       Interaction with target DNA.
FT                                {ECO:0000250}.
FT   SITE        783    783       Interaction with target DNA.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1     21       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_012809.
FT   VAR_SEQ     406    413       DMSVLNSP -> RYLLKLSS (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_012810.
FT   VAR_SEQ     414   1251       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_012811.
FT   VAR_SEQ     479    479       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10094488,
FT                                ECO:0000303|PubMed:11278384}.
FT                                /FTId=VSP_012812.
FT   VARIANT     138    138       V -> M (in dbSNP:rs3087403).
FT                                /FTId=VAR_021249.
FT   VARIANT     257    257       F -> S (in dbSNP:rs3087386).
FT                                /FTId=VAR_021250.
FT   VARIANT     306    306       N -> D (in dbSNP:rs28382882).
FT                                /FTId=VAR_029193.
FT   VARIANT     373    373       N -> S (in dbSNP:rs3087399).
FT                                /FTId=VAR_021251.
FT   VARIANT     656    656       M -> V (in dbSNP:rs3087394).
FT                                /FTId=VAR_029194.
FT   VARIANT     660    660       L -> W (in dbSNP:rs3087398).
FT                                /FTId=VAR_029195.
FT   VARIANT     700    700       D -> N (in dbSNP:rs28382941).
FT                                /FTId=VAR_029196.
FT   VARIANT     704    704       R -> Q (in dbSNP:rs28382942).
FT                                /FTId=VAR_029197.
FT   VARIANT     902    902       P -> H (in dbSNP:rs28382961).
FT                                /FTId=VAR_029199.
FT   VARIANT     902    902       P -> S (in dbSNP:rs28382960).
FT                                /FTId=VAR_029198.
FT   VARIANT     921    921       S -> I (in dbSNP:rs3087396).
FT                                /FTId=VAR_029200.
FT   VARIANT    1003   1003       A -> T (in dbSNP:rs3087401).
FT                                /FTId=VAR_024436.
FT   VARIANT    1060   1060       P -> T (in dbSNP:rs3087388).
FT                                /FTId=VAR_029201.
FT   VARIANT    1074   1074       N -> K (in dbSNP:rs3087393).
FT                                /FTId=VAR_029202.
FT   VARIANT    1091   1091       N -> T (in dbSNP:rs3087392).
FT                                /FTId=VAR_029203.
FT   VARIANT    1102   1102       L -> P (in dbSNP:rs3087400).
FT                                /FTId=VAR_029204.
FT   MUTAGEN     570    570       D->A: Abolishes transferase activity;
FT                                when associated with A-571.
FT                                {ECO:0000269|PubMed:11278384}.
FT   MUTAGEN     571    571       E->A: Abolishes transferase activity;
FT                                when associated with A-570.
FT                                {ECO:0000269|PubMed:11278384}.
FT   TURN         48     51       {ECO:0000244|PDB:2EBW}.
FT   STRAND       53     56       {ECO:0000244|PDB:2EBW}.
FT   HELIX        64     73       {ECO:0000244|PDB:2EBW}.
FT   STRAND       84     86       {ECO:0000244|PDB:2EBW}.
FT   STRAND       89     91       {ECO:0000244|PDB:2EBW}.
FT   HELIX        99    102       {ECO:0000244|PDB:2EBW}.
FT   STRAND      104    106       {ECO:0000244|PDB:2EBW}.
FT   HELIX       112    120       {ECO:0000244|PDB:2EBW}.
FT   HELIX       127    129       {ECO:0000244|PDB:2EBW}.
FT   HELIX       345    355       {ECO:0000244|PDB:3GQC}.
FT   HELIX       357    375       {ECO:0000244|PDB:3GQC}.
FT   HELIX       384    387       {ECO:0000244|PDB:3GQC}.
FT   STRAND      419    424       {ECO:0000244|PDB:3GQC}.
FT   HELIX       427    432       {ECO:0000244|PDB:3GQC}.
FT   TURN        433    435       {ECO:0000244|PDB:3GQC}.
FT   TURN        437    441       {ECO:0000244|PDB:3GQC}.
FT   STRAND      444    446       {ECO:0000244|PDB:3GQC}.
FT   HELIX       463    471       {ECO:0000244|PDB:3GQC}.
FT   TURN        472    475       {ECO:0000244|PDB:3GQC}.
FT   HELIX       500    502       {ECO:0000244|PDB:3GQC}.
FT   STRAND      509    511       {ECO:0000244|PDB:3GQC}.
FT   HELIX       513    516       {ECO:0000244|PDB:3GQC}.
FT   TURN        517    519       {ECO:0000244|PDB:3GQC}.
FT   HELIX       526    532       {ECO:0000244|PDB:3GQC}.
FT   STRAND      537    539       {ECO:0000244|PDB:3GQC}.
FT   HELIX       543    558       {ECO:0000244|PDB:3GQC}.
FT   STRAND      564    568       {ECO:0000244|PDB:3GQC}.
FT   STRAND      571    575       {ECO:0000244|PDB:3GQC}.
FT   HELIX       577    583       {ECO:0000244|PDB:3GQC}.
FT   HELIX       587    602       {ECO:0000244|PDB:3GQC}.
FT   STRAND      606    613       {ECO:0000244|PDB:3GQC}.
FT   HELIX       614    624       {ECO:0000244|PDB:3GQC}.
FT   STRAND      629    631       {ECO:0000244|PDB:3GQC}.
FT   HELIX       634    636       {ECO:0000244|PDB:3GQC}.
FT   HELIX       637    643       {ECO:0000244|PDB:3GQC}.
FT   HELIX       646    648       {ECO:0000244|PDB:3GQC}.
FT   HELIX       654    662       {ECO:0000244|PDB:3GQC}.
FT   HELIX       668    671       {ECO:0000244|PDB:3GQC}.
FT   HELIX       676    683       {ECO:0000244|PDB:3GQC}.
FT   HELIX       685    694       {ECO:0000244|PDB:3GQC}.
FT   TURN        695    697       {ECO:0000244|PDB:3GQC}.
FT   STRAND      712    716       {ECO:0000244|PDB:3GQC}.
FT   HELIX       725    745       {ECO:0000244|PDB:3GQC}.
FT   STRAND      748    760       {ECO:0000244|PDB:3GQC}.
FT   STRAND      776    790       {ECO:0000244|PDB:3GQC}.
FT   HELIX       793    805       {ECO:0000244|PDB:3GQC}.
FT   HELIX       811    813       {ECO:0000244|PDB:3GQC}.
FT   STRAND      814    826       {ECO:0000244|PDB:3GQC}.
FT   STRAND     1160   1162       {ECO:0000244|PDB:3VU7}.
FT   HELIX      1165   1178       {ECO:0000244|PDB:4EXT}.
FT   HELIX      1184   1199       {ECO:0000244|PDB:4EXT}.
FT   HELIX      1203   1218       {ECO:0000244|PDB:4EXT}.
FT   HELIX      1223   1243       {ECO:0000244|PDB:4EXT}.
FT   STRAND     1245   1248       {ECO:0000244|PDB:4EXT}.
SQ   SEQUENCE   1251 AA;  138248 MW;  010E261D537DBA80 CRC64;
     MRRGGWRKRA ENDGWETWGG YMAAKVQKLE EQFRSDAAMQ KDGTSSTIFS GVAIYVNGYT
     DPSAEELRKL MMLHGGQYHV YYSRSKTTHI IATNLPNAKI KELKGEKVIR PEWIVESIKA
     GRLLSYIPYQ LYTKQSSVQK GLSFNPVCRP EDPLPGPSNI AKQLNNRVNH IVKKIETENE
     VKVNGMNSWN EEDENNDFSF VDLEQTSPGR KQNGIPHPRG STAIFNGHTP SSNGALKTQD
     CLVPMVNSVA SRLSPAFSQE EDKAEKSSTD FRDCTLQQLQ QSTRNTDALR NPHRTNSFSL
     SPLHSNTKIN GAHHSTVQGP SSTKSTSSVS TFSKAAPSVP SKPSDCNFIS NFYSHSRLHH
     ISMWKCELTE FVNTLQRQSN GIFPGREKLK KMKTGRSALV VTDTGDMSVL NSPRHQSCIM
     HVDMDCFFVS VGIRNRPDLK GKPVAVTSNR GTGRAPLRPG ANPQLEWQYY QNKILKGKAA
     DIPDSSLWEN PDSAQANGID SVLSRAEIAS CSYEARQLGI KNGMFFGHAK QLCPNLQAVP
     YDFHAYKEVA QTLYETLASY THNIEAVSCD EALVDITEIL AETKLTPDEF ANAVRMEIKD
     QTKCAASVGI GSNILLARMA TRKAKPDGQY HLKPEEVDDF IRGQLVTNLP GVGHSMESKL
     ASLGIKTCGD LQYMTMAKLQ KEFGPKTGQM LYRFCRGLDD RPVRTEKERK SVSAEINYGI
     RFTQPKEAEA FLLSLSEEIQ RRLEATGMKG KRLTLKIMVR KPGAPVETAK FGGHGICDNI
     ARTVTLDQAT DNAKIIGKAM LNMFHTMKLN ISDMRGVGIH VNQLVPTNLN PSTCPSRPSV
     QSSHFPSGSY SVRDVFQVQK AKKSTEEEHK EVFRAAVDLE ISSASRTCTF LPPFPAHLPT
     SPDTNKAESS GKWNGLHTPV SVQSRLNLSI EVPSPSQLDQ SVLEALPPDL REQVEQVCAV
     QQAESHGDKK KEPVNGCNTG ILPQPVGTVL LQIPEPQESN SDAGINLIAL PAFSQVDPEV
     FAALPAELQR ELKAAYDQRQ RQGENSTHQQ SASASVPKNP LLHLKAAVKE KKRNKKKKTI
     GSPKRIQSPL NNKLLNSPAK TLPGACGSPQ KLIDGFLKHE GPPAEKPLEE LSASTSGVPG
     LSSLQSDPAG CVRPPAPNLA GAVEFNDVKT LLREWITTIS DPMEEDILQV VKYCTDLIEE
     KDLEKLDLVI KYMKRLMQQS VESVWNMAFD FILDNVQVVL QQTYGSTLKV T
//
